John Snisarenko

Mr. John Snisarenko is an Independent Director at Cytophage Technologies Ltd. and a Non-Executive Chairman at Zentek Ltd. He is on the Board of Directors at Cytophage Technologies Ltd. Mr. Snisarenko was previously employed as a Chief Commercial Officer by Oyster Point Pharma, Inc., an Independent Director by Alimera Sciences, Inc., a Vice President & Head-Business Unit by Novartis Ophthalmics, Inc., a Group VP & Head-Ophthalmology Franchise by Novartis Pharmaceuticals Corp., a Group Vice President-Ophthalmology Business Unit by Takeda Pharmaceuticals U.S.A., Inc., a Vice President-Sales & Marketing by Genentech, Inc., a Vice President & General Manager-Ophthalmology by Novadaq Technologies, Inc., a Vice President by Novartis Pharmaceuticals Canada, Inc., and a VP-Sales & Marketing-Ophthalmics Unit by Ciba Vision Corp.
He also served on the board at The Foundation Fighting Blindness, Inc. He received his undergraduate degree from McGill University and an MBA from McGill University.